MMedication Read More Oral Wegovy Captures One-Third of Prescriptions as Adoption Continues to AccelerateJune 18, 2026 tablets pills medicine bottle NEW SIZE ©PXHere Novo Nordisk (NYSE:NVO) is seeing strong uptake of its oral Wegovy…
HHealth care Read More 3 Ridiculously Cheap Healthcare Stocks to Buy in JuneJune 13, 2026 Quick Read NVO sits 44% below its 52-week high with a price-to-free-cash-flow of 5 and a free cash…
MMedication Read More Novo’s Wegovy Pill Isn’t Just Beating Expectations — It’s Obliterating Them. Is the Beaten-Down Stock a Buy Now?June 11, 2026 The pharmaceutical industry is highly competitive and driven by innovation. Those two facts couldn’t be on any clearer…
MMedication Read More Can Wegovy Pill’s Rapid Uptake Give Novo Nordisk an Edge Over LLY?June 8, 2026 Novo Nordisk NVO remains one of the dominant players in the rapidly expanding obesity treatment market. The company markets…
MMedication Read More Why Canadians can now get cheaper generic OzempicJune 5, 2026 Elizabeth Doran has been taking GLP-1 medications for nearly a year for weight loss to help reverse her…
HHealth Read More GLP-1 drugs may have a beneficial effect across many types of cancerJune 3, 2026 By Nancy Lapid June 3 (Reuters) – A growing body of evidence suggests that popular GLP-1 drugs, widely…
HHealth care Read More Novo Nordisk faces complex GLP-1 landscape as oral launch patterns diverge from injectablesJune 2, 2026 Novo Nordisk faces complex GLP-1 landscape as oral launch patterns diverge from injectables Proactive uses images sourced from…
MMedication Read More Weight Loss Drugs Listed By Health Insurers Aren’t Necessarily CoveredJune 2, 2026 Eli Lilly’s Foundayo weight loss oral pill competes against Novo Nordisk’s oral Wegovy. (Photo by: Michael Siluk/UCG/Universal Images…
MMedication Read More Brazil approves first generic semaglutide pen after Ozempic patent expiryMay 26, 2026 SAO PAULO, May 26 (Reuters) – Brazil’s health regulator Anvisa said on Tuesday it had approved EMS’s Ozivy,…
MMedication Read More How GLP-1s are more than just weight-loss wonders – but not without riskMay 23, 2026 Not long ago, nobody was talking about GLP-1 receptor agonists. Most of us did not even know what…
HHealth Read More Lilly and Novo Weight-Loss Drugs Show Potential Cancer BenefitsMay 23, 2026 This article first appeared on GuruFocus. Eli Lilly (LLY, Financials) and Novo Nordisk (NVO, Financials) may have another…
MMedication Read More LLY Stock: Foundayo Data Bolsters Weight-Loss Maintenance CaseMay 22, 2026 Shares of Eli Lilly and Company NYSE: LLY, the world’s most valuable pharmaceutical stock, started 2026 in a…